Literature DB >> 16135561

Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference.

Michael F Green1, Berend Olivier, Jacqueline N Crawley, David L Penn, Steven Silverstein.   

Abstract

This article summarizes the discussion from a breakout group at the National Institute of Mental Health-Measurement and Treatment Research to Improve Cognition in Schizophrenia New Approaches Conference on social cognition in schizophrenia. During this discussion, the reasons for the recent growth of research on social cognition in schizophrenia were examined. The discussion group established consensus on several points, including the importance of viewing social cognition from interdisciplinary perspectives (including outcomes research, social psychology, cognitive psychology, cognitive neuroscience, and animal models) and the need for clearer definition of terms. There was also general agreement that social cognition is a valuable construct for understanding the nature and disability of schizophrenia. One of the objectives of this group was to generate recommendations for subsequent human and animal studies, and these research agendas are summarized in this report.

Entities:  

Mesh:

Year:  2005        PMID: 16135561     DOI: 10.1093/schbul/sbi049

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  96 in total

1.  Interactive decision-making in people with schizotypal traits: a game theory approach.

Authors:  Mascha van 't Wout; Alan G Sanfey
Journal:  Psychiatry Res       Date:  2010-06-09       Impact factor: 3.222

2.  Predicting social functioning in schizotypy: an investigation of the relative contributions of theory of mind and mood.

Authors:  Amanda McCleery; Marielle Divilbiss; Annie St-Hilaire; Jennifer M Aakre; James P Seghers; Emily K Bell; Nancy M Docherty
Journal:  J Nerv Ment Dis       Date:  2012-02       Impact factor: 2.254

Review 3.  Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends.

Authors:  Seth Kurzban; Lisa Davis; John S Brekke
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

4.  Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects.

Authors:  Shaun M Eack; Gerard E Hogarty; Deborah P Greenwald; Susan S Hogarty; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2006-10-19       Impact factor: 4.939

5.  How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia.

Authors:  John S Brekke; Maanse Hoe; Jeffrey Long; Michael F Green
Journal:  Schizophr Bull       Date:  2007-01-25       Impact factor: 9.306

6.  The effects of clonidine on discrete-trial delayed spatial alternation in two rat models of memory loss.

Authors:  Mark E Bardgett; Megan Points; Christian Ramsey-Faulkner; Jeff Topmiller; John Roflow; Travis McDaniel; Timberly Lamontagne; Molly S Griffith
Journal:  Neuropsychopharmacology       Date:  2007-09-19       Impact factor: 7.853

7.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

8.  Assessment of social judgments and complex mental states in the early phases of psychosis.

Authors:  Shannon M Couture; David L Penn; Jean Addington; Scott W Woods; Diana O Perkins
Journal:  Schizophr Res       Date:  2008-02-05       Impact factor: 4.939

Review 9.  Psychosocial treatments to promote functional recovery in schizophrenia.

Authors:  Robert S Kern; Shirley M Glynn; William P Horan; Stephen R Marder
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

10.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.